Huiying Wang

Huiying Wang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2019 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
HWHuiying Wang
Huiying Wang
MMMitra Mehrad
Mitra Mehrad
KEKim A. Ely
Kim A. Ely
JLJiancong Liang
Jiancong Liang
CSCarmen C. Solórzano
Carmen C. Solórzano
VWVivian Weiss
Vivian Weiss

1 December 2020 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
SKShu-Chen Kuo
Shu-Chen Kuo
MTMei-Chen Tan
Mei-Chen Tan
WHWei-Cheng Huang
Wei-Cheng Huang
HWHan-Chieh Wu
Han-Chieh Wu
FCFeng-Jui Chen
Feng-Jui Chen
TLTsai-Ling Lauderdale
Tsai-Ling Lauderdale
We aimed to determine susceptibilities of Elizabethkingia spp. to 25 commonly tested and 8 novel antibiotics, and to compare the performance of different susceptibility testing methods. Clinical isolates of Elizabethkingia spp., Chryseobacterium spp. and Flavobacterium spp. collected during 2002–18 (n = 210) in a nationwide surveillance programme in Taiwan were speciated by 16S rRNA sequencing. MICs were determined by broth microdilution. The broth microdilution results of 18 common antibiotics were compared with those obtained by the VITEK 2 automated system. Among the Elizabethkingia spp. identified (n = 108), Elizabethkingia anophelis was the most prevalent (n = 90), followed by Elizabethkingia meningoseptica (n = 7) and Elizabethkingia miricola cluster [E. miricola (n = 6), Elizabethkingia bruuniana (n = 3) and Elizabethkingia ursingii (n = 2)]. Most isolates were recovered from respiratory or blood specimens from hospitalized, elderly patients. PFGE showed two major and several minor E. anophelis clones. All isolates were resistant to nearly all the tested β-lactams. Doxycycline, minocycline and trimethoprim/sulfamethoxazole inhibited >90% of Elizabethkingia spp. Rifampin inhibited E. meningoseptica (100%) and E. anophelis (81.1%). Fluoroquinolones and tigecycline were active against E. meningoseptica and E. miricola cluster isolates. Novel antibiotics, including imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam, delafloxacin, eravacycline and omadacycline were ineffective but lascufloxacin inhibited half of Elizabethkingia spp. The very major discrepancy rates of VITEK 2 were >1.5% for ciprofloxacin, moxifloxacin and vancomycin. Major discrepancy rates were >3% for amikacin, tigecycline, piperacillin/tazobactam and trimethoprim/sulfamethoxazole. MDR, absence of standard interpretation criteria and poor intermethod concordance necessitate working guidelines to facilitate future research of emerging Elizabethkingia spp.

19 February 2020 in Head and Neck Pathology
Verified
Journal Article
Closed access
PDF file
HWHuiying Wang
Huiying Wang
VWVivian L. Weiss
Vivian L. Weiss
RHRobert D. Hoffman
Robert D. Hoffman
TATy Abel
Ty Abel
RHRichard H. Ho
Richard H. Ho
JLJiancong Liang
Jiancong Liang

1 November 2017 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
AUArun Upadhyaya
Arun Upadhyaya
PZPingping Zhou
Pingping Zhou
ZMZhaowei Meng
Zhaowei Meng
PWPeng Wang
Peng Wang
GZGuizhi Zhang
Guizhi Zhang
WZWan Zhang
Wan Zhang
This study aimed to examine the radioprotective effect of vitamin E on salivary glands after radioactive iodine (131I) therapy in patients with differentiated thyroid cancer. Eighty-two patients with differentiated thyroid cancer were enrolled in this study. They were divided randomly into four groups (control group: 22 cases, group A: 23 cases, group B: 22 cases, and group C: 15 cases) before postsurgical ablation therapy with 100 mCi 131I. The patients in groups A, B, and C received vitamin E 100, 200, and 300 mg/day orally, respectively, for a duration of 1 week before to 4 weeks after 131I therapy. Salivary gland function was assessed using salivary gland scintigraphy immediately before and 6 months after 131I therapy. Uptake fraction (UF), uptake index (UI), excretion fraction (EF), and excretion ratio (ER) of each salivary gland were measured and compared. On comparison between before and after 131I therapy in the control group, there was a significant decrease in UF of both right and left parotid glands (all P<0.01). In group A, a significant increase in EF of the right parotid gland (P<0.01) and UI of the right submandibular gland (P<0.05) was found. In group B, there was a significant increase in UI of the right parotid gland and both submandibular glands (all P<0.01). In group C, there was a significant increase in UF of the left parotid gland (P<0.05) and the right submandibular gland (P<0.01). Also, there was a statistical increase in UI in both submandibular glands (all P<0.01). However, on comparing the changes in the post-131I therapy salivary scintigraphy parameters among the four groups, there was a significant difference in ΔUI of the right parotid gland (P<0.05) and both submandibular glands (all P<0.01), as well as ΔER of the left parotid gland (P<0.05) and ΔUF of the left submandibular gland (P<0.05). Vitamin E exerts significant protective effects on the parotid and submandibular glands after 131I therapy.

4 September 2019 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
PDF file
HWHuiying Wang
Huiying Wang
HCHernan Correa
Hernan Correa
MSMelinda Sanders
Melinda Sanders
WNWallace W Neblett
Wallace W Neblett
JLJiancong Liang
Jiancong Liang
Background: Papillary thyroid carcinoma (PTC) in children has a distinctive set of clinicopathologic features and molecular signature compared to their adult counterparts. The recent recommendation to reclassify encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) without invasion as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is based on evidence derived almost exclusively from studies in adults. Clinicopathologic studies restricted to pediatric NIFTP are limited. Methods: We retrospectively analyzed all pediatric PTC and NIFTP diagnosed and treated in our institution from 1999 to 2016 (n = 31). Results: Using recently published consensus diagnostic criteria, we identified 3 NIFTP and 2 infiltrative follicular variants of papillary thyroid carcinoma (FVPTC) among 31 cases. Two of the NIFTP cases were initially diagnosed as EFVPTC. All 3 patients with NIFTP had unifocal tumors of lower American Joint Committee on Cancer (AJCC) classification (T2 or lower) and were free of lymph node or distant metastasis. Total (n = 1) or completion (n = 2) thyroidectomy was performed in all cases, and only 1 NIFTP patient received subsequent radioablative therapy. No residual or recurrent disease has been observed during follow-up (15–138 months) in patients with NIFTP. Conclusions: Our experience with NIFTP in children is similar to outcomes reported in adult studies, suggesting that pediatric NIFTP behave indolently as evidenced by the absence of local recurrence in our cohort.

1 July 2021 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
HWHuiying Wang
Huiying Wang
VWVivian Weiss
Vivian Weiss
SBScott C. Borinstein
Scott C. Borinstein
KEKim Ely
Kim Ely
JJJoyce Johnson
Joyce Johnson
JLJiancong Liang
Jiancong Liang